Previous close | 66.70 |
Open | 66.80 |
Bid | 67.51 x 2200 |
Ask | 67.37 x 1300 |
Day's range | 66.63 - 67.40 |
52-week range | 53.63 - 71.70 |
Volume | |
Avg. volume | 7,252,101 |
Market cap | 208.868B |
Beta (5Y monthly) | 0.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.44 (2.15%) |
Ex-dividend date | 24 Feb 2022 |
1y target est | N/A |
Over the past six months, the market has fallen sharply thanks to a toxic combination of fears about a looming recession, rising inflation, and rising interest rates. Growth stocks and unprofitable companies have been especially hard hit. Sanofi (NASDAQ: SNY) is a multinational pharma giant with a market cap in excess of $135 billion, and its shares are up by over 17% from six months ago.
European Commission authorizes a booster dose of AstraZeneca's (AZN) COVID-19 vaccine and approves Merck (MRK) and Roche's (RHHBY) oncology drugs for expanded use.
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), The Walt Disney Company (DIS) and NextEra Energy, Inc. (NEE).